VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 4,903

Sort by:

Acinetobacter Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Acinetobacter Infections Drug pipeline report- 2020 is an annual R&D review of Acinetobacter Infections pipeline candidates. The report presents the current status of all major Acinetobacter Infection...

October 2019 150 pages

African Trypanosomiasis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

African Trypanosomiasis Drug pipeline report- 2020 is an annual R&D review of African Trypanosomiasis pipeline candidates. The report presents the current status of all major African Trypanosomiasis t...

October 2019 40 pages

Anthrax Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Anthrax Drug pipeline report- 2020 is an annual R&D review of Anthrax pipeline candidates. The report presents the current status of all major Anthrax therapeutic compounds. Detailed insights into Ant...

October 2019 70 pages

Aspergillosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Aspergillosis Drug pipeline report- 2020 is an annual R&D review of Aspergillosis pipeline candidates. The report presents the current status of all major Aspergillosis therapeutic compounds. Detailed...

October 2019 80 pages

Bacillary Dysentery (Shigellosis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Bacillary Dysentery (Shigellosis) Drug pipeline report- 2020 is an annual R&D review of Bacillary Dysentery (Shigellosis) pipeline candidates. The report presents the current status of all major Bacil...

October 2019 40 pages

Bacterial Vaginosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Bacterial Vaginosis Drug pipeline report- 2020 is an annual R&D review of Bacterial Vaginosis pipeline candidates. The report presents the current status of all major Bacterial Vaginosis therapeutic c...

October 2019 50 pages

Botulism Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Botulism Drug pipeline report- 2020 is an annual R&D review of Botulism pipeline candidates. The report presents the current status of all major Botulism therapeutic compounds. Detailed insights into...

October 2019 40 pages

Burkholderia pseudomallei Infections (Melioidosis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Burkholderia pseudomallei Infections (Melioidosis) Drug pipeline report- 2020 is an annual R&D review of Burkholderia pseudomallei Infections (Melioidosis) pipeline candidates. The report presents the...

October 2019 50 pages

Candidiasis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Candidiasis Drug pipeline report- 2020 is an annual R&D review of Candidiasis pipeline candidates. The report presents the current status of all major Candidiasis therapeutic compounds. Detailed insig...

October 2019 130 pages

Chagas Disease (American Trypanosomiasis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Chagas Disease (American Trypanosomiasis) Drug pipeline report- 2020 is an annual R&D review of Chagas Disease (American Trypanosomiasis) pipeline candidates. The report presents the current status of...

October 2019 70 pages

Chikungunya Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Chikungunya Fever Drug pipeline report- 2020 is an annual R&D review of Chikungunya Fever pipeline candidates. The report presents the current status of all major Chikungunya Fever therapeutic compoun...

October 2019 80 pages

Chlamydia Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Chlamydia Infections Drug pipeline report- 2020 is an annual R&D review of Chlamydia Infections pipeline candidates. The report presents the current status of all major Chlamydia Infections therapeuti...

October 2019 50 pages

Cholera Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Cholera Drug pipeline report- 2020 is an annual R&D review of Cholera pipeline candidates. The report presents the current status of all major Cholera therapeutic compounds. Detailed insights into Cho...

October 2019 50 pages

Coccidioidomycosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Coccidioidomycosis Drug pipeline report- 2020 is an annual R&D review of Coccidioidomycosis pipeline candidates. The report presents the current status of all major Coccidioidomycosis therapeutic comp...

October 2019 40 pages

Community Acquired Pneumonia Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Community Acquired Pneumonia Drug pipeline report- 2020 is an annual R&D review of Community Acquired Pneumonia pipeline candidates. The report presents the current status of all major Community Acqui...

October 2019 70 pages

Cryptococcosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Cryptococcosis Drug pipeline report- 2020 is an annual R&D review of Cryptococcosis pipeline candidates. The report presents the current status of all major Cryptococcosis therapeutic compounds. Detai...

October 2019 40 pages

Cryptosporidiosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Cryptosporidiosis Drug pipeline report- 2020 is an annual R&D review of Cryptosporidiosis pipeline candidates. The report presents the current status of all major Cryptosporidiosis therapeutic compoun...

October 2019 40 pages

Dengue Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Dengue Fever Drug pipeline report- 2020 is an annual R&D review of Dengue Fever pipeline candidates. The report presents the current status of all major Dengue Fever therapeutic compounds. Detailed in...

October 2019 150 pages

Diphtheria Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Diphtheria Drug pipeline report- 2020 is an annual R&D review of Diphtheria pipeline candidates. The report presents the current status of all major Diphtheria therapeutic compounds. Detailed insights...

October 2019 70 pages

Epstein–Barr Virus (HHV-4) Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Epstein–Barr Virus (HHV-4) Infections Drug pipeline report- 2020 is an annual R&D review of Epstein–Barr Virus (HHV-4) Infections pipeline candidates. The report presents the current status of all maj...

October 2019 90 pages

Genital Herpes Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Genital Herpes Drug pipeline report- 2020 is an annual R&D review of Genital Herpes pipeline candidates. The report presents the current status of all major Genital Herpes therapeutic compounds. Detai...

October 2019 70 pages

Gonorrhea Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Gonorrhea Drug pipeline report- 2020 is an annual R&D review of Gonorrhea pipeline candidates. The report presents the current status of all major Gonorrhea therapeutic compounds. Detailed insights in...

October 2019 50 pages

Haemophilus influenzae Type B Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Haemophilus influenzae Type B Infections Drug pipeline report- 2020 is an annual R&D review of Haemophilus influenzae Type B Infections pipeline candidates. The report presents the current status of a...

October 2019 60 pages

Hand, Foot and Mouth Disease Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Hand, Foot and Mouth Disease Drug pipeline report- 2020 is an annual R&D review of Hand, Foot and Mouth Disease pipeline candidates. The report presents the current status of all major Hand, Foot and...

October 2019 40 pages

Hepatitis A Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Hepatitis A Drug pipeline report- 2020 is an annual R&D review of Hepatitis A pipeline candidates. The report presents the current status of all major Hepatitis A therapeutic compounds. Detailed insig...

October 2019 30 pages

Hepatitis D Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Hepatitis D Drug pipeline report- 2020 is an annual R&D review of Hepatitis D pipeline candidates. The report presents the current status of all major Hepatitis D therapeutic compounds. Detailed insig...

October 2019 50 pages

Hepatitis E Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Hepatitis E Drug pipeline report- 2020 is an annual R&D review of Hepatitis E pipeline candidates. The report presents the current status of all major Hepatitis E therapeutic compounds. Detailed insig...

October 2019 30 pages

Herpes Labialis (Oral Herpes) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Herpes Labialis (Oral Herpes) Drug pipeline report- 2020 is an annual R&D review of Herpes Labialis (Oral Herpes) pipeline candidates. The report presents the current status of all major Herpes Labial...

October 2019 50 pages

Herpes Zoster (Shingles) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Herpes Zoster (Shingles) Drug pipeline report- 2020 is an annual R&D review of Herpes Zoster (Shingles) pipeline candidates. The report presents the current status of all major Herpes Zoster (Shingles...

October 2019 50 pages

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Drug pipeline report- 2020 is an annual R&D review of Hospital Acquired Methicillin-Resistant Staphylococcus aureus (...

October 2019 40 pages

Hospital Acquired Pneumonia (HAP) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Hospital Acquired Pneumonia (HAP) Drug pipeline report- 2020 is an annual R&D review of Hospital Acquired Pneumonia (HAP) pipeline candidates. The report presents the current status of all major Hospi...

October 2019 80 pages

Human Parainfluenza Virus Type 3 Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Human Parainfluenza Virus Type 3 Infections Drug pipeline report- 2020 is an annual R&D review of Human Parainfluenza Virus Type 3 Infections pipeline candidates. The report presents the current statu...

October 2019 40 pages

Impetigo Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Impetigo Drug pipeline report- 2020 is an annual R&D review of Impetigo pipeline candidates. The report presents the current status of all major Impetigo therapeutic compounds. Detailed insights into...

October 2019 30 pages

Influenza A Virus, H3N2 Subtype Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Influenza A Virus, H3N2 Subtype Infections Drug pipeline report- 2020 is an annual R&D review of Influenza A Virus, H3N2 Subtype Infections pipeline candidates. The report presents the current status...

October 2019 120 pages

Influenza A Virus, H5N1 Subtype Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Influenza A Virus, H5N1 Subtype Infections Drug pipeline report- 2020 is an annual R&D review of Influenza A Virus, H5N1 Subtype Infections pipeline candidates. The report presents the current status...

October 2019 130 pages

Influenza A Virus, H7N9 Subtype Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Influenza A Virus, H7N9 Subtype Infections Drug pipeline report- 2020 is an annual R&D review of Influenza A Virus, H7N9 Subtype Infections pipeline candidates. The report presents the current status...

October 2019 60 pages

Influenzavirus B Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Influenzavirus B Infections Drug pipeline report- 2020 is an annual R&D review of Influenzavirus B Infections pipeline candidates. The report presents the current status of all major Influenzavirus B...

October 2019 100 pages

Japanese Encephalitis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Japanese Encephalitis Drug pipeline report- 2020 is an annual R&D review of Japanese Encephalitis pipeline candidates. The report presents the current status of all major Japanese Encephalitis therape...

October 2019 40 pages

Klebsiella pneumoniae Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Klebsiella pneumoniae Infections Drug pipeline report- 2020 is an annual R&D review of Klebsiella pneumoniae Infections pipeline candidates. The report presents the current status of all major Klebsie...

October 2019 100 pages

Lassa Fever (Lassa Hemorrhagic Fever) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Lassa Fever (Lassa Hemorrhagic Fever) Drug pipeline report- 2020 is an annual R&D review of Lassa Fever (Lassa Hemorrhagic Fever) pipeline candidates. The report presents the current status of all maj...

October 2019 50 pages

Leishmaniasis (Kala-Azar) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Leishmaniasis (Kala-Azar) Drug pipeline report- 2020 is an annual R&D review of Leishmaniasis (Kala-Azar) pipeline candidates. The report presents the current status of all major Leishmaniasis (Kala-A...

October 2019 100 pages

Lyme Disease Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Lyme Disease Drug pipeline report- 2020 is an annual R&D review of Lyme Disease pipeline candidates. The report presents the current status of all major Lyme Disease therapeutic compounds. Detailed in...

October 2019 50 pages

Lymphatic Filariasis (Elephantiasis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Lymphatic Filariasis (Elephantiasis) Drug pipeline report- 2020 is an annual R&D review of Lymphatic Filariasis (Elephantiasis) pipeline candidates. The report presents the current status of all major...

October 2019 30 pages

Marburgvirus Infections (Marburg Hemorrhagic Fever) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Marburgvirus Infections (Marburg Hemorrhagic Fever) Drug pipeline report- 2020 is an annual R&D review of Marburgvirus Infections (Marburg Hemorrhagic Fever) pipeline candidates. The report presents t...

October 2019 60 pages

Measles Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Measles Drug pipeline report- 2020 is an annual R&D review of Measles pipeline candidates. The report presents the current status of all major Measles therapeutic compounds. Detailed insights into Mea...

October 2019 40 pages

Meningitis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Meningitis Drug pipeline report- 2020 is an annual R&D review of Meningitis pipeline candidates. The report presents the current status of all major Meningitis therapeutic compounds. Detailed insights...

October 2019 30 pages

Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections Drug pipeline report- 2020 is an annual R&D review of Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections pipeline candidate...

October 2019 40 pages

Middle East Respiratory Syndrome (MERS) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Middle East Respiratory Syndrome (MERS) Drug pipeline report- 2020 is an annual R&D review of Middle East Respiratory Syndrome (MERS) pipeline candidates. The report presents the current status of all...

October 2019 70 pages

Mumps Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Mumps Drug pipeline report- 2020 is an annual R&D review of Mumps pipeline candidates. The report presents the current status of all major Mumps therapeutic compounds. Detailed insights into Mumps pip...

October 2019 40 pages

Neisseria meningitidis Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs US$ 1,699.00

Neisseria meningitidis Infections Drug pipeline report- 2020 is an annual R&D review of Neisseria meningitidis Infections pipeline candidates. The report presents the current status of all major Neiss...

October 2019 70 pages